Personalis

$32.51
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.68 (+5.45%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Personalis and other stocks, options, and ETFs commission-free!

About PSNL

Personalis, Inc. engages in the provision of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in 2011 and is headquartered in Menlo Park, CA. The listed name for PSNL is Personalis, Inc. Common Stock.

CEO
John S. West
Employees
182
Headquarters
Menlo Park, California
Founded
2011
Market Cap
1.49B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.11M
High Today
$33.82
Low Today
$31.61
Open Price
$31.69
Volume
1.01M
52 Week High
$53.46
52 Week Low
$4.27

PSNL Earnings

-$0.89
-$0.66
-$0.44
-$0.21
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
-$0.29 per share
Actual
-$0.34 per share
Replay Earnings Call

You May Also Like

AGIO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure